• Latest Posts

Innovent starts trial of mazdutide in Chinese adults with obesity

First patient with peripheral T cell lymphoma dosed with Yingli Pharma’s linperlisib

CellOrigin Biotech and Qilu Pharmaceutical to develop CAR-iMAC cell therapy

Astellas ‘encouraged’ by menopause symptom treatment results in China

Neukio Biotherapeutics completes financing round for development of cell therapy products

Labiotech adds conference and event listings


Strategic collaboration announced in China to accelerate the development of bacterial drugs

Sanyou and KangaBio to collaborate on antibody drug development and innovation

Alpha Biopharma announces completion of phase 2/3 clinical study for drug to treat lung cancer

Ascletis is first Chinese biotech company to get IND approvals for oral RdRp inhibitor

World’s first CAR-T for treatment of inflammatory disorders of the central nervous system approved in China

Gilead to acquire remaining worldwide rights of breast cancer drug, Trodelvy